Biochemical evaluation of X-linked hypophosphatemia and tumor-induced osteomalacia: insights into diagnosis and management
The recommendations for performing biochemical screening for XLH and TIO promote better clinical practices in patient diagnosis and management. Future research should focus on validating diagnostic methods in diverse populations and standardizing biochemical tests. Multidisciplinary approach to the diagnosis of these patients through the close collaboration of professionals of laboratory medicine and clinical specialties would be pivotal.
Authors
- Jorge Díaz–Garzón (ORCID: https://orcid.org/0000-0002-3171-1505)
- Pilar Fernández–Calle (ORCID: https://orcid.org/0000-0002-7823-593X)
- P. Aguado (ORCID: https://orcid.org/0009-0006-1623-5287)
- Esteban Jódar Gimeno
- Vanessa Lopes Martín
- María Luisa González‐Casaus (ORCID: https://orcid.org/0000-0002-1268-7191)
Institutions
- Hospital Universitario La Paz (ES)
- Hospital Universitario Quirónsalud Madrid (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Universidad Europea de Madrid (ES)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3389/fendo.2025.1702656
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00